WOLVERINE ASSET MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,289,952
+12.2%
14,400
+6.7%
0.01%
+7.7%
Q2 2023$1,149,390
+20.8%
13,500
+17.4%
0.01%
+18.2%
Q1 2023$951,625
+146.9%
11,500
+134.7%
0.01%
+175.0%
Q4 2022$385,385
+68.3%
4,900
+58.1%
0.00%
+100.0%
Q3 2022$229,000
-82.5%
3,100
-83.2%
0.00%
-81.8%
Q3 2021$1,305,000
-39.6%
18,497
-43.0%
0.01%
-31.2%
Q2 2021$2,160,00032,4340.02%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders